Business · 04/08/1998Updated: 10/17/2026 · 1 min read
FDA Approves Clenbuterol Syrup for Horses with COPD
The FDA is amending animal drug regulations to approve a new animal drug application for Boehringer Ingelheim Animal Health, Inc.'s clenbuterol syrup, which treats airway obstruction in horses with chronic obstructive pulmonary disease (COPD).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →